Infervision

Infervision is a world's leading high-tech enterprise in medical artificial intelligence. Aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome and lower cost, Infervision is using A.I. and deep learning technologies to develop multiple platforms, including an A.I. applications management platform, an A.I. data-mining research platform, and several A.I. clinical application platforms, as well as medical A.I. systems for quality control, health management, and scientific research. Infervision provides advanced, intelligent, and systematic services to payor, provider, and patients, and truly realizes "Advancing Technology, Inspiring Healthcare."

As of October 2020, Infervision has service-sites covering North America, Asia-Pacific and Europe region, with the presence in over ten countries worldwide. So far, our AI is processing sixty-four thousands daily cases, and helped with over twenty six million cases cumulatively. By 2020, Infervision's AI products have gained several regulatory clearances, including PMDA in Jpan, CE, the FDA 510(k), and the NMPA of China.